Related by context. Frequent words. (Click for all words.) 65 androgen deprivation 65 androgen independent 63 interferon therapy 63 heavily pretreated 62 hormonal therapies 62 castration resistant prostate cancer 62 neoadjuvant therapy 62 HER2 positive metastatic breast 61 superficial bladder cancer 61 elevated CRP 61 poorer prognosis 61 peginterferon 61 neoadjuvant chemotherapy 61 juvenile idiopathic arthritis 61 Zolinza 61 HER2 positive breast cancer 61 medullary thyroid cancer 61 metastatic hormone refractory 61 abiraterone acetate 60 hormonal therapy 60 cabazitaxel 60 Herceptin trastuzumab 60 Trastuzumab 60 malignant pleural mesothelioma 60 abiraterone 60 mycophenolate mofetil 60 vasomotor symptoms 60 nilotinib 60 interferon alfa 60 endometrial cancers 60 allogeneic stem cell 60 metastatic prostate cancer 59 KRAS mutations 59 carcinoid tumors 59 chronic HCV 59 neoadjuvant 59 bladder cancers 59 sustained virologic response 59 OncoVEX GM CSF 59 bone metastasis 59 Testicular cancer 59 Advanced Prostate Cancer 59 dasatinib 59 community AABB SmartBrief 59 systemic lupus erythematosus SLE 59 metastatic renal cell carcinoma 58 Natalizumab 58 tamoxifen therapy 58 chronic lymphocytic leukemia CLL 58 hypoparathyroidism 58 XELOX 58 fulvestrant 58 indolent NHL 58 decitabine 58 acute myelogenous leukemia AML 58 EGFR inhibitors 58 chemoradiotherapy 58 endocrine therapy 58 Benign Prostatic Hyperplasia 58 HER2 positive 58 mRCC 58 Vandetanib 58 hypercalcemia 58 acute GVHD 58 Cell Lung Cancer 58 Gemzar ® 58 HER2 negative 58 secondary hyperparathyroidism 58 hormonal treatments 58 HCV infected 58 disease modifying antirheumatic 58 bicalutamide 58 nab paclitaxel 58 ovarian breast 58 Alemtuzumab 58 goserelin 58 renal toxicity 58 Combination therapy 57 Irinotecan 57 luteinizing hormone releasing 57 estrogen receptor negative 57 anticancer therapy 57 Taxotere ® 57 oophorectomy 57 CMV disease 57 Jevtana 57 tyrosine kinase inhibitors 57 gastrointestinal stromal tumors 57 Pegasys ® 57 serum testosterone 57 HCV infection 57 biologic therapy 57 pazopanib 57 recurrent ovarian cancer 57 grade gliomas 57 HGS ETR1 57 pancreatic NET 57 lupus nephritis 57 pertuzumab 57 Asentar 57 Epratuzumab